Michlewska, S.; Ionov, M.; Szwed, A.; Rogalska, A.; Sanz del Olmo, N.; Ortega, P.; Denel, M.; Jacenik, D.; Shcharbin, D.; de la Mata, F.J.;
et al. Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells. Int. J. Mol. Sci. 2020, 21, 4119.
https://doi.org/10.3390/ijms21114119
AMA Style
Michlewska S, Ionov M, Szwed A, Rogalska A, Sanz del Olmo N, Ortega P, Denel M, Jacenik D, Shcharbin D, de la Mata FJ,
et al. Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells. International Journal of Molecular Sciences. 2020; 21(11):4119.
https://doi.org/10.3390/ijms21114119
Chicago/Turabian Style
Michlewska, Sylwia, Maksim Ionov, Aleksandra Szwed, Aneta Rogalska, Natalia Sanz del Olmo, Paula Ortega, Marta Denel, Damian Jacenik, Dzmitry Shcharbin, Francisco Javier de la Mata,
and et al. 2020. "Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells" International Journal of Molecular Sciences 21, no. 11: 4119.
https://doi.org/10.3390/ijms21114119
APA Style
Michlewska, S., Ionov, M., Szwed, A., Rogalska, A., Sanz del Olmo, N., Ortega, P., Denel, M., Jacenik, D., Shcharbin, D., de la Mata, F. J., & Bryszewska, M.
(2020). Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells. International Journal of Molecular Sciences, 21(11), 4119.
https://doi.org/10.3390/ijms21114119
